Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9275 USD | +6.46% | +5.84% | -13.32% |
Mar. 21 | Transcript : MiNK Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
Mar. 21 | MiNK Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Number of employees: 31
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Zack Armen
IRC | Investor Relations Contact | - | - |
Treasurer | 58 | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Brian Corvese
BRD | Director/Board Member | 67 | 17-06-30 |
Peter Behner
BRD | Director/Board Member | 61 | 21-03-31 |
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,699,056 | 9,944,796 ( 28.66 %) | 0 | 28.66 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.32% | 32.18M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- INKT Stock
- Company MiNK Therapeutics, Inc.